Conzelmann and colleagues aimed to gain information about outcomes of transcatheter aortic valve replacement (TAVR) procedures in patients with coronary heights less than 7 mm. These procedures are not common, as one of the contraindications for TAVR is a low coronary height.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
TAVR (TAVI)
November 7, 2018
Why this study – the rationale/objective
November 7, 2018
The authors of this study analyzed neurological events and quality-of-life in the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial. A total of 1746 patients with aortic stenosis and intermediate surgical risk were randomized to either TAVI or SAVR.
October 25, 2018
Olaf Wendler of King's College Hospital in London, UK, presents a discussion on the 2017 ESC/EACTS guidelines for the management of valvular heart disease.
October 17, 2018
Find it here: the 32nd EACTS Annual Meeting in Milan, Italy
October 14, 2018
Despite the benefit for most patients, some patients have poor outcome after transcatheter aortic valve implantation (TAVI). Currently it is hard to predict which patient is predisposed to poor outcome at one year. This paper investigates the performance of a previously developed prediction model of poor outcome after TAVI.
October 12, 2018
Patient Care and General Interest
A family in Atlanta, Georgia, USA, whose 13-month-old daughter was born with pulmonic stenosis, has adopted a dog with the same congenital heart defect.
September 28, 2018
Patient Care and General Interest
Saturday, September 29 is World Heart Day! This year’s theme is “My Heart, Your Heart.”
September 16, 2018
Results of a clinical trial using transcatheter aortic valve replacement provided a "strong signal" that it is safe for patients with low surgical risk, potentially helping to open the way for broader use of the minimally invasive procedure, also known as TAVR.
September 13, 2018
Torsten Doenst of the University Heart Center Thuringen in Germany presents a discussion on the importance of long-term durability when considering conventional versus transcatheter valves.